A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : CURE / Clopidogrel in Unstable Angina to Prevent Recurrent Events

[Related PubMed/MEDLINE]
Total Number of Papers: 36
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   CURE  (>> Co-occurring Abbreviation)
Long Form:   Clopidogrel in Unstable Angina to Prevent Recurrent Events
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2012 Effect of PON1 Q192R genetic polymorphism on clopidogrel efficacy and cardiovascular events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events trial and the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events. CI, HR
2011 Randomized trial of atopaxar in the treatment of patients with coronary artery disease: the lessons from antagonizing the cellular effect of Thrombin–Coronary Artery Disease Trial. LANCELOT-CAD, TIMI
2011 Safety and tolerability of atopaxar in the treatment of patients with acute coronary syndromes: the lessons from antagonizing the cellular effects of Thrombin–Acute Coronary Syndromes Trial. ---
2011 Unravelling the benefit against the risk of long-term dual antiplatelet therapy. ACS, DAPT, PCI
2008 Cost-effectiveness of clopidogrel treatment in percutaneous coronary intervention: a European model based on a meta-analysis of the PCI-CURE, CREDO and PCI-CLARITY trials. CLARITY, CREDO, PCI, QALYs
2007 Clinical use of clopidogrel in acute coronary syndrome. ACS, NSTEMI, PCI
2007 Cost-effectiveness of clopidogrel in acute coronary syndromes in Canada: a long-term analysis based on the CURE trial. ASA, PCI-CURE
2007 Renal function and outcomes in acute coronary syndrome: impact of clopidogrel. CI, RR
2007 Stroke and the statistics of the aspirin/clopidogrel secondary prevention trials. CAPRIE, MATCH
10  2006 A cost analysis in patients with acute coronary syndrome using clopidogrel in addition to aspirin in a Hong Kong public hospital. ACS
11  2006 Clopidogrel to treat patients with non-ST-segment elevation acute coronary syndromes after hospital discharge. ACC/AHA, CABG, NSTE-ACS, PCI
12  2006 [Bleeding complications after treatment with clopidogrel and acetylsalicylic acid after acute coronary syndrome]. ASA, NSTEMI, UAP
13  2005 Benefit of clopidogrel according to timing of percutaneous coronary intervention in patients with acute coronary syndromes: further results from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. ACSs, CV, MI, NSTE, PCI, RR
14  2005 CLARITY about the use of clopidogrel in patients with acute coronary syndromes and myocardial infarction. CLARITY
15  2005 Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis. ADP, ASA, CAPRIE, CREDO, MI
16  2005 Clopidogrel: cardiologists' panacea or neurologists' headache? CAPRIE, CLARITY-TIMI, CREDO
17  2005 Differences in the management and prognosis of women and men who suffer from acute coronary syndromes. ACS, CABG, MI, TIMI
18  2005 Long-term cost-effectiveness of clopidogrel given for up to one year in patients with acute coronary syndromes without ST-segment elevation. ACS, ICER, LYG
19  2005 Use of antiplatelet agents and anticoagulants for cardiovascular disease: current standards and best practices. ACS
20  2004 Antiplatelet drugs in ischemic stroke prevention: from monotherapy to combined treatment. ESPRIT
21  2004 Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. CABG, CV, MI, PCI, RR
22  2004 Comparative benefits of clopidogrel and aspirin in high-risk patient populations: lessons from the CAPRIE and CURE studies. ASA, CAPRIE
23  2004 Controversies of oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention. ACS, CREDO, MI, PCI
24  2004 Long-term combination therapy with aspirin and clopidogrel. MATCH
25  2004 The value of clopidogrel in addition to standard therapy in reducing atherothrombotic events. ACS, CREDO, LYG, PCI-CURE
26  2003 Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study. ACS, RR
27  2003 Platelet activation in patients with congestive heart failure: do we have enough evidence to consider clopidogrel? CAPRIE, CHF, PLUTO-CHF, WATCH
28  2003 Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention. ACS, MI
29  2003 The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study: to what extent should the results be generalizable? ---
30  2003 The role of clopidogrel in the management of acute coronary syndromes. ACS, ASA, CREDO, MI, PCI, PCI-CURE
31  2003 What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention? PCI
32  2002 Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups. CI, RR, TIMI
33  2002 Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes. ---
34  2002 Clopidogrel: a CURE in acute coronary syndromes? ACSs, LMWH, MI
35  2002 Is CURE a cure for acute coronary syndromes? Statistical versus clinical significance. ---
36  2000 The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease. ---